TransactedยทTuesday, April 14, 2026ยท5 min readFintech
๐พ Paid "too much"
Thoma Bravo's restructuring of Medallia highlights risks in ARR-based lending and signals a shift in private equity strategies.
The newsletter provides critical insights into Thoma Bravo's restructuring efforts with Medallia, a situation that underscores the risks associated with ARR-based lending. As the company faces significant debt challenges, this case serves as a cautionary tale for investors relying on recurring revenue metrics without adequate cash flow. Additionally, the winding down of Thoma Bravo's growth equity strategy suggests a broader trend in private equity, where firms may be refocusing on more traditional buyout strategies amidst changing market conditions.
On a more positive note, the newsletter highlights emerging funding opportunities in the fintech and healthcare sectors, with startups like Round and Ultralight successfully raising seed capital. This indicates that while some areas of private equity may be cooling off, there remains robust investor interest in innovative tech solutions within these industries, presenting potential avenues for venture capital investment.
Key Takeaways
- Thoma Bravo is restructuring Medallia amid significant debt challenges, marking a potential shift in private credit dynamics.
- The firm's growth equity strategy is winding down, indicating a refocus on core buyout strategies.
- Emerging fintech and healthcare startups are securing seed funding, suggesting continued investor interest in these sectors.
FintechHealth TechPrivate Equity